Clinical Trials Directory

Trials / Unknown

UnknownNCT03306251

National Cohort of Children Born to HIV-positive Mothers

ANRS CO11 : National Cohort of Children Born to HIV-positive Mothers

Status
Unknown
Phase
Study type
Observational
Enrollment
5,200 (estimated)
Sponsor
ANRS, Emerging Infectious Diseases · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

Detailed description

The goal of the CO11 national cohort is to provide with CO1 a wider surveillance system to monitor changes in the rate of mother to child transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs. The CO11 EPF enrolle HIV infected women who delivery in maternity generally smaller than CO1 maternity (15 sites in Paris area, 35 in mainland France and 4 in the DOM). Maternal clinical, biological and therapeutic data before and during pregnancy were collected at delivery, with simplified questionnaires. The children are examined clinically and biologically at birth, 6, 12 and 24 months.

Conditions

Timeline

Start date
2005-06-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2017-10-11
Last updated
2021-04-30

Locations

52 sites across 4 countries: France, French Guiana, Guadeloupe, Martinique

Source: ClinicalTrials.gov record NCT03306251. Inclusion in this directory is not an endorsement.

National Cohort of Children Born to HIV-positive Mothers (NCT03306251) · Clinical Trials Directory